Tuesday, January 20, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Acme United Reports Q4 2023 Earnings Sales Fall Short of Estimates

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_Investment (2)
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Acme United, a leading provider of safety solutions and innovative technology, released its Q4 2023 earnings on March 1, 2024. The company reported an adjusted EPS of $0.400, which fell short of the analyst consensus estimate of $0.550 by 27.27%. Quarterly sales totaled $41.900 million, missing the analyst consensus estimate of $46.309 million by 9.52%. This marks a 5.00% decrease from sales of $44.104 million in the same period last year.

Specializing in products for schools, homes, offices, hardware, sports, and industrial sectors, Acme United is known for brands like First Aid Only®, PhysiciansCare®, and Westcott®. For more information about Acme United, please visit their official website at www.acmeunited.com.

ACU Stock Price Drops by 14.72% – What Caused the Decline and What Investors Should Know

On March 1, 2024, ACU stock experienced a significant drop in price, decreasing by $6.99 or 14.72% since the previous market close. The stock opened at $46.03, which was $1.47 lower than its previous close. This decline in price momentum may have been unexpected for investors who were closely monitoring the stock’s performance.

Investors may be wondering what caused this sudden drop in ACU’s stock price. It is important to consider various factors that could have influenced this decline, such as market conditions, company news, or industry trends. It is always important for investors to conduct thorough research and analysis before making any investment decisions.

For those who are already invested in ACU, this drop in price may be concerning. It is crucial for investors to stay informed about the company’s financial health, performance, and any potential risks that may impact the stock’s value in the future.

ACU Inc. Stock Performance Disappoints Investors in Latest Financial Data – March 1, 2024

On March 1, 2024, investors in ACU Inc. may have been disappointed to see the stock’s performance based on the latest financial data released by the company. According to CNN Money, ACU’s total revenue for the past year was $193.96 million, which represented a 6.52% increase compared to the previous year. However, the total revenue for the third quarter of the fiscal year was $50.38 million, showing a 5.53% decrease compared to the previous quarter.

The net income for ACU Inc. was reported to be $3.03 million for the past year, which was a significant decrease of 77.78% compared to the previous year. The net income for the third quarter of the fiscal year was $2.15 million, showing a decrease of 37.5% compared to the previous quarter.

Earnings per share (EPS) for ACU Inc. were reported to be $0.82 for the past year, which represented a decrease of 76.37% compared to the previous year. The EPS for the third quarter of the fiscal year was $0.58, showing a decrease of 39.69% compared to the previous quarter.

Tags: ACU
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Interlink Electronics Inc Announces 50 Common Stock Dividend for Stockholders

Finances and charts

Analyst David Grossman Reiterates Buy Rating on Veeva Systems and Raises Price Target

Financing

BMO Capital Analyst Reiterates Market Perform Rating for Autodesk with Increased Price Target

Recommended

Soleno Therapeut. Stock

Soleno Therapeutics: A Biotech Saga of Stellar Sales and Serious Allegations

5 months ago
Viking Therapeutics Stock

Viking Therapeutics Shares Plummet Following Clinical Trial Data Release

5 months ago
UPS Stock

UPS Delivers Stunning Earnings Beat Through Aggressive Restructuring

3 months ago
Oracle Stock

Oracle’s High-Stakes AI Gamble Raises Alarm Bells

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Southern Copper Shares Pause Ahead of Earnings Release

Analyst Downgrade Weighs on Intellia Therapeutics Shares

Fiserv Stock: A Critical Juncture for the Payments Giant

The Trade Desk Stock: A Deep Value Opportunity Emerges from the Selloff

Enovix Shares Surge on Battery Validation, Yet Scaling Challenges Loom

Hecla Mining Shares Surge on Unprecedented Silver Rally

Trending

FutureFuel Stock
Chemicals

FutureFuel Shares Maintain Upward Momentum as Strategy Gains Traction

by Felix Baarz
January 20, 2026
0

FutureFuel Corp. has opened the new year with notable strength, with its equity advancing approximately 6.0% since...

Max Power Mining Stock

A Strategic Stake and a Historic Discovery: Max Power Mining Gains Momentum

January 20, 2026
Synopsys Stock

Synopsys Stock Navigates Strategic Shift Amid Divergent Investor Views

January 20, 2026
Southern Copper Stock

Southern Copper Shares Pause Ahead of Earnings Release

January 20, 2026
Intellia Therapeutics Stock

Analyst Downgrade Weighs on Intellia Therapeutics Shares

January 20, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • FutureFuel Shares Maintain Upward Momentum as Strategy Gains Traction
  • A Strategic Stake and a Historic Discovery: Max Power Mining Gains Momentum
  • Synopsys Stock Navigates Strategic Shift Amid Divergent Investor Views

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com